Novo Nordisk has sued rival GLP-1 drugmaker Eli Lilly in federal court, alleging misleading advertis

Novo Nordisk (NYSE:NVO) has filed a federal lawsuit against Eli Lilly, alleging that its rival's adv

LLY's leadership in obesity drugs, expanding pipeline and stronger growth outlook set it apart as in

Ozempic drugmaker Novo Nordisk sued rival GLP-1 manufacturer Eli Lilly in federal court Tuesday, acc

The drugmaker says Lilly isn't including the most up-to-date clinical information about its drugs

The maker of Ozempic and Wegovy says its competitor is misleading consumers by citing outdated weigh

Novo Nordisk filed a lawsuit against Eli Lilly, alleging that its advertising campaigns for its bloc

Citi has raised its price target on Novo Nordisk (NYSE:NVO) to DKK330 ahead of second-quarter result

MichaelAaron Flicker examines the growing impact of GLP-1 medications on consumer behavior, noting t

Viking Therapeutics just launched its next-gen weight loss program. Novo Nordisk and Eli Lilly are a

Novo Nordisk is pulling ahead of Eli Lilly in the market for oral weight loss medicines. Eli Lilly h

Following a careful analysis of the Zacks Oil and Gas - Refining & Marketing MLP industry, we advise

Fractyl Health NASDAQ: GUTS reported one-year data from the randomized midpoint cohort of its REMAIN

Up to 84% of GLP-1 induced weight loss retained with Revita® versus 46% with sham at one year in pat

Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings a

    During Wednesday's morning trading, 251 companies set new 52-week highs.

    Before 10 a.m. ET on Tuesday, 166 companies hit new 52-week highs.

    Monday's morning session saw 253 companies set new 52-week highs.

Stocks That Hit 52-Week Lows On Wednesday

Stocks That Hit 52-Week Lows On Thursday

Stocks That Hit 52-Week Lows On Friday

Stocks That Hit 52-Week Lows On Thursday